Researchers in Norway have opened a clinical trial testing the UV1 cancer vaccine in combination with the drugs Opdivo and Yervoy to treat mesothelioma.
Researchers in Norway have opened a clinical trial testing the UV1 cancer vaccine in combination with the drugs Opdivo and Yervoy to treat mesothelioma.
Comments are closed.